William Carson, MD
Enriched profileProfessor of Surgery, Division of Surgical Oncology; Vice Chair of Surgery for Promotion and Tenure; Associate Director for Clinical Research, OSUCCC – James · The Ohio State University Comprehensive Cancer Center (OSUCCC – James)
William Carson is Professor of Surgery, Division of Surgical Oncology; Vice Chair of Surgery for Promotion and Tenure; Associate Director for Clinical Research, OSUCCC – James at The Ohio State University Comprehensive Cancer Center (OSUCCC – James). OpenAlex indexes 687 publications with 20,951 citations (h-index 76); ClinicalTrials.gov lists 16 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Surgical Oncology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
William E. Carson III, MD, is Professor of Surgery, Division of Surgical Oncology at The Ohio State University Comprehensive Cancer Center (OSUCCC – James) / Ohio State University Wexner Medical Center, Department of Surgery. The public record shows 687 publications with 20,951 citations (h-index 76), centered on Immune Cell Function and Interaction, Immune cells in cancer, Cancer Immunotherapy and Biomarkers. It also documents an investigator role on 16 registered clinical trials, 19 NIH-funded awards (1997–2026).
- Most recent indexed publication: 2026 · Cancer immunology research
- Top research focus: Immune Cell Function and Interaction
- 16 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 24 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 256.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 16 registered studies on ClinicalTrials.gov. The most recent:
- A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma
Sponsor: Ohio State University Comprehensive Cancer Center
- Prospective Pilot Study of Robot-assisted Nipple Sparing Mastectomy (RNSM)
Sponsor: Ohio State University Comprehensive Cancer Center
- Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
Sponsor: Ohio State University Comprehensive Cancer Center
Industry payments
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
NIH funding
Updated 27 Aug 2026
19 NIH research awards on record, funded 1997–2026 per NIH RePORTER. The latest:
- The Ohio State University as a Lead Academic Organization (LAO) for the Experimental Therapeutics Clinical Trials Network
Ohio State University
FY2026$1,697,412UM1CA186712 - Dual-payload antibody-drug conjugate for chemo-immunotherapy of triple-negative breast cancers
Ohio State University
FY2026$569,570R01CA281980
Congress activity
Updated 27 Aug 2026
69 congress contributions (2005–2026) across AACR, ASCO, ASH, ASTRO, ESMO, SABCS per OpenAlex. The most recent:
- Abstract 732: Targeting adenosine A2B receptor using PBF-1129 in treating patients with metastatic non-small cell lung cancer
AACR Annual Meeting
AACR2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Phase II Trial of Interleukin-12 Followed by Interferon Alfa-2b in Patients with Metastatic Malignant Melanoma: Results from CALGB 500001 (Alliance).
Cancer immunology research
Clinical Trial2026 - Trabectedin Enhances the Antitumor Effects of IL-12 in Triple-Negative Breast Cancer.
Cancer immunology research
Article2025 - Targeting Myeloid-Derived Suppressor Cells via Dual-Antibody Fluorescent Nanodiamond Conjugate.
Nanomaterials (Basel, Switzerland)
Article2024 - Racial disparities in disease-specific mortality and surgical management of patients with ductal carcinoma in situ with microinvasion.
Journal of surgical oncology
Article2024
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- ResearchGate
researchgate.net/profile/William-Carson-9
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - X / Twitter
x.com/carsonlabosu
Mentions by others
where others cite or feature them- Other
cancer.osu.edu/find-a-doctor/search-physician-directory/william-e-carson-iii
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.osu.edu ↗ - LinkedIn
LinkedIn profile: "William Carson - Professor of Surgery at The Ohio State University Comprehensive Cancer Center"
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
- Board Certified
American Board of Surgery
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →advancement.osu.edu ↗
Editorial & leadership roles
journal and society appointments- Vice-Chair
SWOG (Southwest Oncology Group) Melanoma Committee, succeeded Dr. Lawrence Flaherty of Karmanos Cancer Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →wexnermedical.osu.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →advancement.osu.edu ↗
Secondary affiliations
appointments beyond the home institution- Roswell Park Cancer Institute
Assistant Professor (past, per ORCID self-attestation)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer